Catch the Latest NCDR-Based Research at the American Heart Association’s Scientific Sessions
Nov. 12-16, 2016 New Orleans, LA

ACTION Registry-GWTG
ACC’s Registry For Acute Myocardial Infarction Treatment

Nov. 13, 4:00–4:10 p.m.
130: Obesity and Long Term Outcomes After ST-elevation Myocardial Infarction in the Elderly: Does the Paradox Extend to Extreme Obesity?: Results From the National Cardiovascular Data Registry – I. Neeland, Moderated Poster, Room 346-347 Elizabeth Barrett-Connor Research Award for Young Investigators in Training Finalists

Nov. 14, 10:45 a.m.– 12:00 p.m.
M4012/4012: Differences in Utilization of Anti-Thrombotic Therapies and Invasive Cardiac Procedures for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the ACTION Registry - GWTG – A. Bagai, Poster, Science and Technology Hall, Clinical Science Section

Nov. 15, 9:00–9:10 a.m.
322: Association of Hospital Excess Readmission Ratio With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the NCDR ACTION Registry-GWTG – A. Pandey, Oral Presentation, Room 238-239

Nov. 15, 12:40–12:45 p.m.
769: Association of Risk Adjusted 30 Day Heart Failure Readmission Rates Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes: Findings From the American Heart Association Get With the Guidelines-Heart Failure Program – A. Pandey, Oral Presentation, Science and Technology Hall, Clinical Science Theater

CathPCI Registry
Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention

Nov. 12, 2:30–2:40 p.m.
102: Differences in Hospital Risk-Standardized Mortality Rates for Acute Myocardial Infarction by Patient Age Group: Implications for Hospital Outcome Profiling – K. Dharmarajan, Moderated Poster, Room 245 Samuel A. Levine Young Clinical Investigator Award Finalists

Nov. 13, 3:45–5:00 p.m.
S4280/4280: Patterns of Use and Outcomes of Antithrombotic Therapy in End Stage Renal Disease Patients Undergoing PCI: Observations From NCDR – J.B. Washam, Moderated Poster, Science and Technology Hall, Clinical Science Section

Nov. 14, 10:45 a.m.–12:00 p.m.
M2093/2093: Prognosis of Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries as Compared With Obstructive Coronary Disease – R. Dreyer, Moderated Poster, Science and Technology Hall, Population Science Section

Nov. 14, 2:00–3:15 p.m.
M2196/2196: Differences in Hospital Risk-Standardized Mortality Rates for Percutaneous Coronary Intervention by Patient Age Group: Implications for Hospital Outcome Profiling – K. Dharmarajan, Moderated Poster, Science and Technology Hall, Population Science Section

Nov. 14, 2:00–3:15 p.m.
M2191/2191: Trends, Predictors and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention: Insights From NCDR CathPCI Registry – R. Nairooz, Moderated Poster, Science and Technology Hall, Population Science Section

ICD Registry
Implantable Cardioverter Defibrillator and Leads Procedures

Nov. 14, 2:00–315 p.m.
M5282/5282: Outcomes and Costs of Remote Patient Monitoring Among Patients With Implanted Cardiac Defibrillators: An Economic Model Based on the PREDICT RM Database – J. Hummel, Moderated Poster, Science and Technology Hall, Clinical Science II Section

Nov. 14, 2:00–3:15 p.m.
M5279/5279: Seattle Heart Failure Model and Seattle Proportional Risk Model Together Identify Patients Most Likely to Benefit From Primary Prevention ICDs - An NCDR Analysis – K. Bilchick, Moderated Poster, Science and Technology Hall, Clinical Science II Section

IMPACT Registry
Pediatric and Adult Congenital Treatment Procedures

Nov. 13, 1:00–1:05 p.m.
535: Variability in Practice Patterns and Consistency With Published Guidelines for Aortic and Pulmonary Balloon Valvuloplasty: An Analysis of Data From the IMPACT Registry – A. Glatz, Rapid Fire Moderated Poster, Science and Technology Hall, Special Focus Theater

Nov. 14, 4:00–4:05 p.m.
723: Variability of Practice Patterns in Device Closure of Atrial Septal Defects and Patent Ductus Arteriosus: An Analysis of Data From the IMPACT Registry – M. O'Byrne, Rapid Fire Moderated Poster, Science and Technology Hall, Special Focus Theater

PINNACLE Registry
Coronary Artery Disease, Heart Failure, Hypertension, Atrial Fibrillation and Diabetes

Nov. 14, 10:45 a.m.–12:00 p.m.
QCOR05/189: Impact of CHA2DS2-VASc Risk Factors on Anticoagulant Prescription in Patients With Atrial Fibrillation: Insights From the NCDR PINNACLE Registry – L. Thompson, Moderated Poster, Science and Technology Hall, Best of Specialty Conferences Section

Nov. 14, 10:45 a.m.–12:00 p.m.
M2071: Practice Level Variation in the Prescription of Direct Oral Anticoagulants: Insights From the NCDR PINNACLE Registry – L. Marzec, Moderated Poster, Science and Technology Hall, Population Science Section

Nov. 14, 10:45 a.m.– 12:00 p.m.
QCOR02/186: Statin Use Before and After the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline – Y. Pokharel, Moderated Poster, Science and Technology Hall, Best of Specialty Conferences Section

Nov. 14, 2:00–3:15 p.m.
M4229: Signs, Symptoms, and Treatment Patterns Across Serial Ambulatory Cardiology Visits in Patients With Heart Failure: Insights From the PINNACLE Registry – S. Turner, Moderated Poster, Science and Technology Hall, Clinical Science Section

STS/ACC TVT Registry
Transcather Valve Replacement and Repair Procedures

Nov. 13, 2:00–3:15 p.m.
S5036/5036: Development of a Risk Prediction Model for 1-Year Mortality after Surgical vs. Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis – S. Baron, Moderated Poster, Science and Technology Hall, Clinical Science Section

Learn more about NCDR research at ACC.org/NCDRResearch.